| Patents for C07C 259 - Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups (4,411) |
|---|
| 05/06/2005 | CA2542210A1 Polymorphic form of n-[(r)-2,3-dihydroxy-propoxy]-3,4-difluoro-2-(2-fluoro-4-iodophenylamino)-benzamide |
| 05/04/2005 | CN1199957C 'Sqiqu site' derivative and its preparing method as well as its activity of anti asthma |
| 05/03/2005 | US6887863 Such as (2RS,3R)-3-amino-4-cyclohexyl-2-hydroxy-N-phenoxybutanamide; methionine aminopeptidase type 2 inhibitors |
| 04/28/2005 | WO2005037779A2 Novel dipeptidyl peptidase iv inhibitors used for functionally influencing different cells and treating immunological, inflammatory, neuronal, and other diseases |
| 04/28/2005 | WO2005037257A2 Novel alanyl-amino peptidase inhibitors for functionally influencing different cells and treating immunological, inflammatory, neuronal, and other diseases |
| 04/28/2005 | WO2005007091A3 Histone deacetylase inhibitors and methods of use thereof |
| 04/28/2005 | US20050090555 Compound for the treatment of metabolic disorders |
| 04/28/2005 | CA2542807A1 Novel dipeptidyl peptidase iv inhibitors used for functionally influencing different cells and treating immunological, inflammatory, neuronal, and other diseases |
| 04/28/2005 | CA2542723A1 Novel alanyl-amino peptidase inhibitors for functionally influencing different cells and treating immunological, inflammatory, neuronal, and other diseases |
| 04/26/2005 | US6884907 Containing carboxylic acid groups; diagnosis; prophylaxis |
| 04/21/2005 | WO2004098582A3 Ketones and reduced ketones as therapeutic agents for the treatment of bone conditions |
| 04/21/2005 | WO2004062601A3 Antibacterial agents |
| 04/21/2005 | US20050085603 Metal complexes of iminohydroxamic acids |
| 04/21/2005 | US20050085550 Polymorphic form of N-[(R)-2,3-dihydroxy-propoxy]-3,4-difluoro-2-(2-fluoro-4-iodophenylamino)-benzamide |
| 04/21/2005 | US20050085517 Novel amino acid derivatives, method for production thereof and pharmaceutical compositions comprising said derivative |
| 04/21/2005 | US20050085507 p-phenylethenyl hydroxamates; anticarcinogenic, antitumor, antiproliferative agents; regulating p21 promoter; improved stability |
| 04/20/2005 | EP1524262A1 Inhibitors of histone deacetylase |
| 04/20/2005 | EP1523470A1 Novel compounds as histone deacetylase inhibitors |
| 04/20/2005 | EP1210330B1 Antibacterial agents |
| 04/20/2005 | EP1165495B1 Resorcinol derivatives |
| 04/20/2005 | CN1608055A Compounds for the treatment of metabolic disorders |
| 04/19/2005 | US6881742 Benzyl amidoxime derivatives, intermediate products and method for their production and use as fungicides |
| 04/14/2005 | WO2005033065A1 Novel amidine compounds for treating microbial infections |
| 04/14/2005 | CA2537791A1 Novel amidine compounds for treating microbial infections |
| 04/06/2005 | CN1603291A Novel intermediates useful for the preparation of antihistaminic piperidine derivatives |
| 03/31/2005 | WO2005028426A1 Novel 4-phenylamino-benzaldoxime derivative and use thereof as mek inhibitor |
| 03/31/2005 | CA2539165A1 Cinnamoyl compound and use of the same |
| 03/31/2005 | CA2538960A1 Cinnamoyl compound and use of the same |
| 03/30/2005 | EP1517884A1 A process for the preparation of 3-cyano-1-naphthoic acid and some analogues thereof |
| 03/30/2005 | CN1602291A Novel bensophenone derivatives or salts thereof |
| 03/24/2005 | WO2005026108A1 Method for producing n,n'-dialkoxy-n,n'-dialkyl oxamide |
| 03/24/2005 | WO2005025619A1 Combination of a histone deacetylase inhibitor with a death receptor ligand |
| 03/24/2005 | CA2539000A1 Combination of a histone deacetylase inhibitor with a death receptor ligand |
| 03/22/2005 | US6870065 Such as N-hydroxysuccinimidyl-5-(N,N-bis-(2-(4-(N-((3-hydroxy-4-(methoxy-carbonyl) phenyl)methyl)carbamoyl) butanoylamino)ethyl)carbamoyl)butanoate for biochemical conjugation |
| 03/16/2005 | CN1193000C Biphenyl derivatives substituted by an aromatic or heteroaromatic radical and pharmaceutical and cometic compositions containing same |
| 03/10/2005 | US20050054877 Enantiomerically selective cyclopropanation |
| 03/09/2005 | EP1511729A1 Histone deacetylase inhibitors based on alphachalcogenmethylcarbonyl compounds |
| 03/09/2005 | EP1511718A1 N-acylaminobenzene dervatives as selective monoamine oxidase b inhibitors |
| 03/03/2005 | WO2005019194A1 Derivatives of hydroxamic acid as metalloproteinase inhibitors |
| 03/03/2005 | WO2005019174A1 Acetylene derivatives as inhibitors of histone deacetylase |
| 03/03/2005 | WO2005019162A1 Hydroxamic acid derivatives and the method for preparing thereof |
| 03/03/2005 | US20050049429 Kinase inhibitors; antiproliferative agents; anticancer agents; psoriasis; restenosis |
| 03/03/2005 | CA2535350A1 Acetylene derivatives as inhibitors of histone deacetylase |
| 03/02/2005 | EP1509495A1 Anilino liver x-receptor modulators |
| 03/02/2005 | EP1509218A1 Peptide deformylase inhibitors |
| 02/24/2005 | US20050043295 Pharmaceutically effective compounds |
| 02/23/2005 | EP1317421B1 2-amino-2-alkyl-5 heptenoic and heptynoic acid derivatives useful as nitric oxide synthase inhibitors |
| 02/23/2005 | CN1585745A Hydroxyfattysulfonic acid analogs |
| 02/22/2005 | US6858626 Cyclic hydroxamic acid as metalloproteinase inhibitors |
| 02/22/2005 | US6858602 Compounds for the treatment of metabolic disorders |
| 02/22/2005 | US6858414 Multistage process for the preparation of highly pure deferoxamine mesylate salt |
| 02/17/2005 | WO2004092115A3 Hydroxamates as therapeutic agents |
| 02/17/2005 | US20050038259 Elastase release inhibitors; such as 19-(1H-tetrazol-5-yl)nonadec-6-en-5-ol |
| 02/16/2005 | EP1425258A4 Hydroxyeicosenoic acid analogs |
| 02/16/2005 | EP1294741B1 Dipeptide inhibitors for the blood-clotting factor xa |
| 02/16/2005 | EP1215203B1 Hydroxamic acid derivatives, process for the production thereof and drugs containing the same as the active ingredient |
| 02/16/2005 | CN1582269A Hydroxyeicosenoic acid analogs |
| 02/16/2005 | CN1189166C FC receptor modulators and uses thereof |
| 02/10/2005 | US20050032831 Histone deacetylase inhibitors and methods of use thereof |
| 02/10/2005 | DE102004034691A1 Use of siderophores for control of odor-producing bacteria, particularly for treating or preventing body odor, act by depriving bacteria of iron |
| 02/09/2005 | EP1436252A4 Hydroxyfattysulfonic acid analogs |
| 02/08/2005 | US6852882 N-(2-(N-formyl-N-hydroxyamino)ethyl)arylamides with bacterial polypeptide deformylase inhibiting activity |
| 02/08/2005 | US6852750 Spinal cord injury, demyelinating diseases, Parkinson's disease, Amyotrophic Lateral Sclerosis, alcohol, nicotine, cocaine dependence, neuropathy, pain and schizophrenia; antiischemic, - carcinogenic agents; NAALADase inhibitors |
| 02/03/2005 | WO2005009940A1 Novel aminobenzophenone compounds |
| 02/03/2005 | CA2530302A1 Novel aminobenzophenone compounds |
| 02/01/2005 | CA2362698C Resorcinol derivatives |
| 01/27/2005 | WO2005007091A2 Histone deacetylase inhibitors and methods of use thereof |
| 01/27/2005 | US20050020680 Hydroxyfattysulfonic acid analogs |
| 01/27/2005 | CA2800212A1 Histone deacetylase inhibitors and methods of use thereof |
| 01/25/2005 | US6846771 Metal complexes of iminohydroxamic acids |
| 01/25/2005 | CA2068224C Novel potent inducers of terminal differentiation and method of use thereof |
| 01/20/2005 | WO2004099124A3 Novel bioisosteres of actinonin |
| 01/20/2005 | US20050014839 Histone deacetylase inhibitors and methods of use thereof |
| 01/20/2005 | US20050014702 Inhibition of pdf enzyme as bactericidal agents for veterinary medicines |
| 01/19/2005 | CN1568306A Hydroxamic acid thrombospondin peptide analog that inhibits aggrecanase activity |
| 01/19/2005 | CN1566065A Alpha position heteroatom substituted gamma aryl ketobutyric acid derivative, process, pharmaceutical combination and uses thereof |
| 01/11/2005 | US6841701 Inhibitors for the blood-clotting factor Xa |
| 01/06/2005 | US20050004115 such as 4-(4-(2-Fluorobenzyloxy)phenyl)-4-oxobutyric acid; for treatment of insulin resistance syndrome, diabetes, hyperlipidemia, fatty liver disease, cachexia, obesity, atherosclerosis and arteriosclerosis |
| 01/05/2005 | EP1492763A1 Carboxamidine derivatives and their use in the treatment of vascular diseases |
| 01/05/2005 | CN1183107C Alkynyl containing hydroxamic acid compounds as TACE inhibitors |
| 01/04/2005 | US6838466 Compounds for the treatment of inflammatory disorders |
| 12/30/2004 | US20040267025 Compounds for the treatment of metabolic disorders |
| 12/30/2004 | US20040267015 Bactericides |
| 12/29/2004 | WO2004064727A3 Method of cancer treatment using hdac inhibitors |
| 12/29/2004 | EP1250316B1 Method for producing n-alkoxy-n-alkylamides |
| 12/29/2004 | CN1182107C Hydroxamic acid derivative as inhibitor of formation of soluble human CD23 |
| 12/28/2004 | US6835753 Administering to the patient for inhibiting Fc receptor binding of immunoglobulin a compound selected from aromatic, heteroaromatic, cyclic, bicyclic and an amino acid derivative or salt |
| 12/23/2004 | WO2004110989A1 N-hydroxy-7-(arylamino)heptanamide derivatives useful for treating hyper-proliferative disorders |
| 12/22/2004 | EP1487426A2 Methods of inducing terminal differentiation |
| 12/21/2004 | US6833384 Deacetylase inhibitors |
| 12/21/2004 | CA2317604C Matrix metalloprotease inhibitors |
| 12/21/2004 | CA2241904C Substituted n-[(aminoiminomethyl or aminomethyl)phenyl]propyl amides |
| 12/16/2004 | WO2004069900A3 Bisaminophenyl-based curatives and amidine-based curatives and cure accelerators for perfluoroelastomeric compositions |
| 12/15/2004 | EP1485348A1 Carbonylamino-derivatives as novel inhibitors of histone deacetylase |
| 12/08/2004 | EP1482924A2 Cathepsin cysteine protease inhibitors |
| 12/08/2004 | EP1240152B1 Ox(adi)azolyl-hydroxamic acids useful as procollagen c-proteinase inhibitors |
| 12/08/2004 | EP1224164B1 Hydroxamic acid derivative as inhibitor of the formation of soluble human cd23 |
| 12/08/2004 | CN1178906C N-hydroxyformamide derivatives as inhibitors of matrix metalloproteinases |
| 12/07/2004 | US6828460 Resorcinol derivatives |
| 12/07/2004 | US6828454 Metal complexes of iminohydroxamic acids |